Immunomedics is committed to be a leading, innovative biopharmaceutical company, dedicated to improving health and quality of life with novel immunotherapeutics for the treatment of cancer, autoimmune and other serious diseases.
Create and deliver breakthrough therapies for hard to treat cancers, transforming patients’ lives.
We will become the leading antibody drug conjugate (ADC) company dedicated to patients – building, developing, manufacturing and commercializing a highly differentiated portfolio of biologic therapies.
Our work is driven by scientific excellence and the highest standards, in a culture of integrity, pride and dedication. In doing so, we create value for our shareholders and a rewarding environment for our employees.
Meet the Leadership
Given our commitment to excellence and innovation, we strive to find the most talented individuals who can support our corporate mission of improving health and the quality of life of patients with novel therapeutics for the treatment of cancer, autoimmune and other serious diseases.
Join Us